Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
David M. Mott is an American businessperson who founded MedImmune Ventures, Inc. and who has been at the head of 18 different companies.

He occupies the position of Chairman of Mersana Therapeutics, Inc., Chairman at Epizyme, Inc., Chairman for Ardelyx, Inc., Chairman for Complexa, Inc., Chairman for Cydan II, Inc., Chairman of Cydan LLC (a subsidiary of Cydan II, Inc.), Chairman of Adaptimmune Therapeutics Plc, Chairman of Imara, Inc. and Chairman at Vtesse, Inc.

He is also on the board of 5 other companies.

In the past Mr. Mott was Chairman for Zyngenia, Inc., Chairman for Sagimet Biosciences, Inc., Executive Vice President of AstraZeneca Plc Vice Chairman, President & Chief Executive Officer at MedImmune LLC, President & Chief Executive Officer for MedImmune Ltd. and President for MedImmune Ventures, Inc. (which are all subsidiaries of AstraZeneca Plc), General Partner for New Enterprise Associates LLC, General Partner at NEA Management Co. LLC, Chairman for Conceptis Technologies, Inc., Chairman of Tesaro, Inc., Chairman-Supervisory Board of Prosensa Holding NV, Chairman of Adaptimmune Ltd., Vice President-Health Care Investment Banking at Smith Barney Harris Upham & Co., Inc. and VP-Health Care Investment Banking Group at Harris Upham & Co, Inc.

He received an undergraduate degree from Dartmouth College.

Current positions of David M. Mott 
NameTitle Since
Novavax, Inc.
(Biotechnology & Medical Research)
Independent Director 2020
Mersana Therapeutics, Inc.
(Biotechnology & Medical Research)
Chairman 2015
Epizyme, Inc.
(Biotechnology & Medical Research)
Chairman 2016
Adaptimmune Therapeutics plc
(Biotechnology & Medical Research)
Chairman 2017
Ardelyx, Inc.
(Biotechnology & Medical Research)
Chairman 2014
(Biotechnology & Medical Research)
Chairman 2016
Cydan II, Inc. Chairman -
Cydan LLC Chairman -
Vtesse, Inc. Chairman -
Biotechnology Innovation Organization Director -
Complexa, Inc. Chairman -
NEA 14 GP Ltd. Director -
XTuit Pharmaceuticals, Inc. Director -
Biohealth Innovation, Inc. Director -

Holdings of David M. Mott 
Novavax, Inc. (NVAX)
(Biotechnology & Medical Research)
64,9610.088%9,589,543 USD
Mersana Therapeutics, Inc. (MRSN)
(Biotechnology & Medical Research)
548,1940.79%7,850,138 USD
Ardelyx, Inc. (ARDX)
(Biotechnology & Medical Research)
417,2840.42%2,983,581 USD
Epizyme, Inc. (EPZM)
(Biotechnology & Medical Research)
268,6460.26%2,210,957 USD
Adaptimmune Therapeutics Plc00.0000%0 USD
(Biotechnology & Medical Research)
00.0000%0 USD

David M. Mott: Personal Network 
Most Read News 
07/12ELON MUSK : Musk tells SolarCity trial that Tesla would 'die' if he wasn't CEO
07/15JAMIE DIMON : Analysis-JPMorgan hoards cash as Dimon expects rates to rise
07/13RICHARD BRANSON : Virgin Galactic acknowledges Branson's pre-launch bike ride never happened
07/20JEFF BEZOS : billionaire Bezos has successful suborbital jaunt
07/13ELON MUSK : Musk defends timing of Tesla's $2.6 billion deal for SolarCity
07/26JEFF BEZOS : Bezos-backed plant food firm NotCo joins unicorn club after latest funding
07/26MICHAEL KLEIN : EV maker Lucid rises in Nasdaq debut after merger with Klein-backed SPAC
07/13BRUNELLO CUCINELLI : Italian luxury group Cucinelli raises 2021 sales forecast again
07/22RYAN COHEN : Flush from Reddit rally, GameStop plots store revival
07/18ALEXANDER NOVAK : Novak says Russia to raise oil output in H2
More news

© 2021 People and Ownership :   
David M. Mott : Connections